Management of Pediatric and Adult Patients with MedulloblastomaAllison Martin, Kenneth J. Cohen, Eric H. Raabe et al.|Current Treatment Options in Oncology|2014Cited by 107
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastomaAllison R. Hanaford, Eric H. Raabe, Jesse Alt et al.|Translational Oncology|2019Cited by 74
PD-L1 expression in medulloblastoma: an evaluation by subgroupAllison Martin, Michael Lim, Christopher J. Nirschl et al.|Oncotarget|2018Cited by 64
Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33Saritha Tantravedi, Venu Raman, Farhad Vesuna et al.|Translational Oncology|2018Cited by 48
PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of <i>BRAF</i> V600E Mutational StatusAllison Martin, Charles G. Eberhart, William R. Bell et al.|Journal of Neuropathology & Experimental Neurology|2019Cited by 16